Cite
miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
MLA
Meng, Ziqi, et al. “MiR-200c/PAI-2 Promotes the Progression of Triple Negative Breast Cancer via M1/M2 Polarization Induction of Macrophage.” International Immunopharmacology, vol. 81, Apr. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2019.106028.
APA
Meng, Z., Zhang, R., Wang, Y., Zhu, G., Jin, T., Li, C., & Zhang, S. (2020). miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage. International Immunopharmacology, 81, N.PAG. https://doi.org/10.1016/j.intimp.2019.106028
Chicago
Meng, Ziqi, Rui Zhang, Yixuan Wang, Guang Zhu, Tiefeng Jin, Chunguo Li, and Songnan Zhang. 2020. “MiR-200c/PAI-2 Promotes the Progression of Triple Negative Breast Cancer via M1/M2 Polarization Induction of Macrophage.” International Immunopharmacology 81 (April): N.PAG. doi:10.1016/j.intimp.2019.106028.